These positive safety and efficacy indicators support the progression of the clinical trial and reinforce confidence in the therapeutic potential of ARO-CFB, thus underpinning the Buy rating.
James Faucette has given his Buy rating due to a combination of factors that reinforce confidence in Mastercard’s growth potential and market positioning. A key element supporting this rating is ...